BOSTON SCIENTIFIC CO (BSX) is drawing unusual attention today. Our newswire has captured 1 story on BSX across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 38/100).
Boston Scientific Co (BSX) stock is moving lower today, down 9.9% in the last eight sessions as the share price declined from $52.01 to $46.84. The drop is attributed to a cybersecurity incident that disrupted the company’s global operations, including order processing and shipping. The incident has raised concerns about operational resilience and potential impacts on revenue, particularly in a sector where consistent service delivery is critical.
Boston Scientific disclosed a cybersecurity threat that has caused a global disruption to its operations. The company is currently investigating the incident, which has affected key functions such as order fulfillment and shipping. This news comes amid a broader market decline, as the Nasdaq 100 fell on rising inflation concerns and renewed rate-hike expectations. The healthcare sector, already under pressure, saw Boston Scientific and other names like Veeva Systems and Lilly highlighted in recent market updates. Boston Scientific’s recall-related issues further contributed to the negative sentiment around the stock.
The stock has a beta of 0.57, indicating it is less volatile than the broader market, but the recent cybersecurity incident has pushed sentiment lower. The 30-day average sentiment score is 44 out of 100, dropping to 39 in the last seven days. Insider activity has been largely positive, with five insider buys totaling $9.5 million in the last 90 days, most recently on August 26. Congressional activity includes recent buys and sells by Rep. Ro Khanna, with the most recent purchase on July 20. Despite these, the stock’s price trend over the past eight sessions has been sharply downward.
Boston Scientific has not scheduled any earnings reports in the immediate future. Investors should monitor the breadth of coverage and the outcome of the ongoing cybersecurity investigation, as well as any follow-up from analysts or regulatory bodies.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Boston Scientific (BSX) trades at about $43, roughly 17% below the recent high it set on 19th Aug, 2026. Its own history with sharp drops is encouraging. That history does not cover a cyberattack it says is likely to hit its 2026 results, and the stock is down about 60% over the past twelve months. Start with the history.
BOSTON SCIENTIFIC CO (BSX) is drawing unusual attention today. Our newswire has captured 1 story on BSX across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 38/100). The most recent driver: "Is This BSX Stock Pullback Worth The Patience?" (Yahoo Top).
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of BSX coverage reads 38/100 over 1 stories; treat it as a research signal and do your own diligence.
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More on BSX: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier BSX move explainers: 2026-08-31 · 2026-08-28